Serum levels of NLRP3 and HMGB-1 are associated with the prognosis of patients with severe blunt abdominal trauma by Sun, Kuanxue & Xia, Hongwei
Serum levels of NLRP3 and HMGB-1 are associated
with the prognosis of patients with severe blunt
abdominal trauma
Kuanxue Sun,I,II Hongwei Xia0000-0001-5054-0564 II,*
IDepartment of General Surgery, GongLi Hospital of Shanghai Pu Dong New District, Shanghai, 200135, China. IIDepartment of Ultrasound, GongLi
Hospital of Shanghai Pu Dong New District, Shanghai, 200135, China.
Sun K, Xia H. Serum levels of NLRP3 and HMGB-1 are associated with the prognosis of patients with severe blunt abdominal trauma. Clinics. 2019;74:e729
*Corresponding author. E-mail: xhw886@aliyun.com
OBJECTIVES: To investigate the relationship between the serum levels of NLRP3 and HMGB-1 and the prognosis
of patients with severe blunt abdominal trauma.
METHODS: In total, 299 patients were included in the current study from July 2014 to December 2015.
All patients were divided into the mild/moderate blunt abdominal trauma group and the severe blunt
abdominal trauma group according to their injury severity scores. Serum levels of NLRP3 and HMGB-1 were
measured upon admission (0 h) and at 12 h, 24 h, 48 h, 72 h and 7 days after admission.
RESULTS: Compared with the healthy controls, both the mild/moderate and severe blunt abdominal trauma
groups had higher serum levels of NLRP3 and HMGB-1 at admission. At all points, the serum levels of NLRP3 and
HMGB-1 were significantly higher in the severe group than in the mild/moderate group. The serum levels of
both NLRP3 and HMGB-1 were significantly higher in the deceased patients than in the living patients. The
Kaplan-Meier curve showed that compared with patients with higher levels of NLRP3 or HMGB-1, those with
lower levels had longer survival times. The serum levels of both NLRP3 and HMGB-1 were independent risk
factors for 6-month mortality in severe blunt abdominal trauma patients.
CONCLUSION: The serum levels of NLRP3 and HMGB-1 were significantly elevated in severe blunt abdominal
trauma patients, and the serum levels of both NLRP3 and HMGB-1 were correlated with 6-month mortality in
severe blunt abdominal trauma patients.
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’ INTRODUCTION
Trauma is the leading cause of death among people
younger than 45 years, and it is also the fourth overall cause
of death regardless of age; therefore, trauma imposes a
substantial economic burden on health care systems (1,2).
More than 180,000 people died of trauma in 2007, and
almost one-third of all emergency department visits are due
to trauma every year (3). Among all types of trauma, abdo-
minal trauma accounts for a large proportion of trauma
cases (4,5).
The most common causes of blunt abdominal trauma
(BAT) are traffic accidents, falls from a height, assaults, and
sports accidents (6,7). In the treatment of BAT, any delay in
the identification of intra-abdominal injuries (IAI) may lead
to morbidity and mortality (8). Thus, a timely and accurate
diagnosis is always critical and may help promptly select an
appropriate treatment strategy. There are many methods of
diagnosing trauma and injury severity, such as exploratory
laparotomy (9) and imaging methods, such as computed
tomography (CT) scans (10). In recent years, the clinical
significance of biomarkers for the diagnosis and prediction of
the prognosis of trauma patients has been widely accepted
(11). Many biomarkers, such as IL-1b (12) and TNF-a (13), are
related to posttraumatic complications, such as systematic
inflammation and sepsis (14).
High mobility group box-1 (HMGB-1), a member of
the alarmin group of cellular messaging proteins, is a
pro-inflammatory cytokine that has been proven to be
associated with posttraumatic inflammation (15,16). Stu-
dies have demonstrated that NACHT domain-, leucine-
rich repeat-, and PYD-containing protein 3 (NLRP3) plays
an important role in HMGB-1-mediated inflammation
in many diseases and bioprocesses. NLRP3 can facilitate
in vivo HMGB-1 release (17), and HMGB-1 can induce an
increase in the level of IL-1b by activating the NLRP3
inflammasome (18). However, to date, no study has
focused on the role of NLRP3 in BAT, and few studies
have reported the relationship between HMGB-1 and the
prognosis of BAT patients.DOI: 10.6061/clinics/2019/e729
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The present study aimed to investigate the relationship
between serum levels of NLRP3 and HMGB-1 and the
prognosis of patients with severe BAT. This study investi-
gated the role of NLRP3 and HMGB-1 in severe BAT and
provides some new treatment targets for the treatment of
severe BAT patients.
’ MATERIALS AND METHODS
Patients
In this study, 299 patients were included. All patients were
diagnosed with BAT from July 2014 to December 2015 in our
hospital. All patients were admitted to our hospital within
12h after experiencing BAT, and the diagnosis of BAT was
confirmed by imaging methods such as CT scans. Patients
were divided into groups according to their different injury
severity scores (ISSs); the mild/moderate BAT group was
defined as patients with ISSso16, and the severe BAT group
was defined as patients with ISSsX16. All patients were
between 18 and 60 years old. Patients with the following
diseases or symptoms were excluded: patients who had severe
infections before BAT; patients with severe systemic diseases
such as severe cardiac, brain, liver, and renal diseases; and
pregnant patients. All patients were treated according to
the local management protocols for abdominal trauma.
In addition, 50 healthy individuals were enrolled as the
healthy controls. Written informed consent was obtained
from all participants or their families within 24 h of admission.
The present study was approved by the ethics committee of
GongLi Hospital of Shanghai Pu Dong New District.
Measurement and data collection
Data including age, sex, causes of injury and ISSs were
recorded. Blood samples were collected upon admission (0 h)
and at 12 h, 24 h, 48 h, 72 h and 7 days after admission. The
serum levels of NLRP3 and HMGB-1 were both determined
by enzyme-linked immunosorbent assay (ELISA) using
commercially available NLRP3 and HMGB-1 ELISA kits
(the HMGB-1 kit was purchased from Shino-Test Corpora-
tion, Kanagawa, Japan, and the NLRP3 kit was purchased
from MyBioSource, San Diego, CA) according to the manu-
facturer’s instructions. For the survival analysis, all-cause
deaths were recorded for patients during hospitalization,
and the follow-up period lasted for 6 months from the time
of admission.
Statistical analysis
The measurement data are expressed as the mean±SD.
The chi-square test was used to compare the rates. Comparisons
between two groups of continuous data were performed with
Student’s t-test, and comparisons among three or more groups
were conducted using one-way analysis of variance (ANOVA)
followed by Tukey’s post hoc test. Kaplan–Meier curves
were generated for the survival analysis, and the relation-
ship between the serum levels of NLRP3 and HMGB-1 and
the 6-month mortality rate of patients was analyzed using
a step-wise logistic regression model. A p-value less than
0.05 was considered statistically significant. All calculations
were performed with SPSS 18.0.
’ RESULTS
Basic clinical information for all participants
The present study included 299 BAT patients. All patients
were divided into the mild/moderate BAT group (n=135),
which had a mean age of 38.15±11.65 years, a male:
female ratio of 86:49, and a mean ISS of 11.78±1.76, and
the severe BAT group (n=164), which had a mean age of
38.17±10.98 years, a male:female ratio of 106:58, and a mean
ISS of 24.25±4.86. The ISS score of the mild/moderate BAT
group was significantly lower than that of the severe BAT
group (po0.05) (Table 1). However, no significant differences
were found with respect to age, gender or the causes of
injury between the 2 groups. During the 6-month follow-up,
15 patients (9.15%) died in the severe BAT group, while all
patients in the mild/moderate BAT group survived.
Dynamic alterations in the levels of NLRP3 and
HMGB-1 in BAT patients in different groups
To study the roles played by NLRP3 and HMGB-1 in BAT
patients, the dynamic alterations in the levels of NLRP3 and
HMGB-1 in different groups of patients were determined at
0 h, 12 h, 24 h, 48 h, 7 2h and 7 days after admission. As
shown in Figure 1, the serum levels of both NLRP3 and
HMGB-1 were significantly higher in the mild/moderate and
severe BAT groups of patients at admission than in the
healthy controls (po0.05). Meanwhile, at all time points, the
serum levels of NLRP3 and HMGB-1 were significantly
higher in the severe BAT group than in the mild/moderate
BAT group (po0.05). The serum levels of both NLRP3 and
HMGB-1 increased at 72h in both patient groups compared
to the levels at admission and then gradually returned to a
normal level. In addition, the levels of NLRP3 and HMGB-1
in all patients at all points were found to be positively
correlated with each other. These results indicated that the
serum levels of NLRP3 and HMGB-1 might be associated
with the effects of BAT.
Table 1 - Basic clinical information of all participants.
Variable Mild/moderate, n=135 Severe, n=164 Control, n=50
Mean age, years 38.15±11.65 (18-60) 38.17±10.98 (18-60) 38.49±10.99 (18-60)
Gender, male:female 86:49 106:58 32:18
Cause of injury, n (%)
Traffic accident 73 (54.1%) 91 (55.5%)
Fall 30 (22.2%) 35 (21.3%)
Assault 23 (17.0%) 26 (15.9%)
Other 9 (6.7%) 12 (7.3%)
Mean ISS 11.78±1.76 24.25±4.86*
Mortality during 6 months of follow-up, n (%) 0 (0%) 15 (9.15%)*
*po0.05, compared with the mild/moderate BAT group.
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Dynamic alterations in the levels of NLRP3 and
HMGB-1 in deceased and living patients with
severe BAT
Then, we investigated the changes in the levels of NLRP3
and HMGB-1 in deceased and living patients in the severe
BAT group. The results showed that at all time points, the
serum levels of NLRP3 and HMGB-1 were significantly
higher in the deceased patients than in the living patients
(po0.05), suggesting that NLRP3 and HMGB-1 levels might
be associated with death in severe BAT patients (Figure 2).
Correlations of NLRP3 and HMGB-1 with 6-month
mortality in severe BAT patients
Finally, we studied the correlation of serum NLRP3 and
HMGB-1 levels with 6-month mortality in severe BAT
patients (Table 2). Because rapid treatment is critical for
patient survival, and the predictive significance of the
serum levels of NLRP3 and HMGB-1 levels might be very
helpful in diagnosing BAT, we investigated the NLRP3 and
HMGB-1 levels at admission. Patients with severe BATwere
divided into high or low NLRP3/HMGB-1 groups according
to their mean serum NLRP3 and HMGB-1 concentrations.
The Kaplan-Meier curve showed that patients with lower
levels of NLRP3 or HMGB-1 had longer survival times than
those of patients with higher levels of NLRP3 or HMGB-1
(po0.05) (Figure 3). The subsequent logistic regression
analysis also showed that the serum levels of both NLRP3
and HMGB-1 at admission were independent risk factors
for 6-month mortality in severe BAT patients.
’ DISCUSSION
It has been reported that traumatic injuries account for
9.6% of the global disease burden and are also the third most
common cause of death in adolescents and adultsp40 years
(19,20). Among all types of trauma, abdominal trauma is one
of the most important causes of morbidity and mortality.
With regard to the treatment of trauma, prompt, accurate
diagnoses are critical to determining the proper treatment
strategy. In addition to traditional diagnostic methods, the
clinical significance of many biomarkers for diagnosing and
predicting the prognosis of numerous conditions has recently
been studied. Among those biomarkers, HMGB-1 and
NLRP3 are 2 newly identified factors that may be associated
with the prognosis of trauma patients. Stahl et al. showed
that patients with multiple severe traumas had significantly
higher HMGB-1 levels than patients who had experienced
moderate trauma or single fractures (21). An animal study
by Liu et al. found that traumatic brain injury can induce
the assembly of the NLRP3-inflammasome complex (22).
Despite these studies, to the best of our knowledge, no study
has focused on the roles played by NLRP3 and HMGB-1 in
the prognosis of BAT patients.
In the present study, we first demonstrated that the serum
levels of NLRP3 and HMGB-1 were significantly higher in
all BAT patients than in the healthy controls, and the serum
levels of NLRP3 and HMGB-1 were significantly higher in
the severe BAT group than in the mild/moderate BAT group.
Wallisch et al. studied the level of NLRP3 in the cerebrospinal
fluid of severe traumatic brain injury patients and found that
the level of NLRP3 was significantly increased in the cerebro-
spinal fluid after severe traumatic brain injury in infants and
children and was also correlated with the ISSs of the patients
(23). In an early study, Peltz et al. demonstrated that plasma
HMGB1 levels were elevated within 1 h of injury in severe
trauma patients more than 30-fold above the levels in healthy
controls (24). All these results are consistent with our findings.
We also found that the levels of NLRP3 and HMGB-1 in all
patients at all time points were positively correlated with
each other. The relationship between NLRP3 and HMGB-1
Figure 1 - Dynamic changes in the serum levels of NLRP3 and HMGB-1 in BAT patients in different groups. A. Dynamic changes in the
level of NLRP3; B. Dynamic changes in the level of HMGB-1; C. Correlation between the serum levels of NLRP3 and HMGB-1. *po0.05,
compared with the mild/moderate group; #po0.05, compared with the controls.
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Figure 3 - Kaplan–Meier curves for patients with high and low NLRP3/HMGB-1 levels.
Figure 2 - Dynamic changes in the serum levels of NLRP3 and HMGB-1 in deceased and living patients. A. Dynamic changes in the level
of NLRP3; B. Dynamic changes in the level of HMGB-1. *po0.05, compared with the living patients.
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has been investigated in many studies. Wei et al. showed that
HMGB-1 promotes the activation of NLRP3 and caspase-8
inflammasomes via the NF-kB pathway in patients with
acute glaucoma (25). Kim et al. found that HMGB-1 pro-
motes IL-1b production in vascular smooth muscle cells
through the activation of the NLRP3 inflammasome (18).
However, until now, no clinical data have supported the
relationship between NLRP3 and HMGB-1 in trauma patients.
Finally, we demonstrated that the serum levels of NLRP3
and HMGB-1 were correlated with 6-month mortality in
severe BAT patients. Sousa et al. found that HMGB-1 levels
were associated with shock within the first 72 h in patients
after severe trauma (26). Zhang et al. demonstrated that
NLRP3 polymorphisms were associated with the develop-
ment of sepsis and multiple organ dysfunction syndrome in
patients with major trauma (27). However, this is the first
study to demonstrate a relationship between the serum levels
of NLRP3 and HMGB-1 and mortality in trauma patients.
In conclusion, we conducted a prospective study to
investigate the role of the serum levels of NLRP3 and
HMGB-1 in the prognosis of patients with severe BAT.
The results showed that the serum levels of NLRP3 and
HMGB-1 were significantly elevated in severe BAT patients,
and the serum levels of NLRP3 and HMGB-1 were correlated
with 6-month mortality in severe BAT patients. This study was
the first to demonstrate the roles played by NLRP3 and
HMGB-1 in patients with severe BAT, providing new targets
for the treatment of severe BAT patients.
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